Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
Patients Prefer Web Access to Test Results
From - Diagnostic Testing & Emerging Technologies
Patients increasingly prefer to receive laboratory test results via password-protected websites and portals, according to…
Remember to Check Excluded Status
From - G2 Compliance Advisor
Background checks aren't just for spotting criminal records. Are you checking the Office of Inspector General's List of…
Theranos Closes Labs to Focus on Technology Instead
From - Diagnostic Testing & Emerging Technologies
Despite appealing the Centers for Medicare and Medicaid's (CMS) sanctions resulting from inspection of…
DEA’s Takeback Initiative Coincides with Quest Survey Highlighting Misuse of Prescription Drugs
From - Laboratory Industry Report
The U.S. Drug Enforcement Administration's latest National Take-Back Initiative happens this month on Oct. 22, when the public is…
Don’t Overlook Bloodborne Pathogen Safety Issues
From - G2 Compliance Advisor
Violations of Medicare-related laws such as the Anti-Kickback Statute, self-referral law and the False Claims Act can cost…
Pay Equity Law Affects What You Can Ask Job Applicants
From - National Intelligence Report
Massachusetts recently signed into law An Act to Establish Pay Equity, S.2119, which takes effect on…
Clinical Single Cell Analysis Shows Promise
From - Diagnostic Testing & Emerging Technologies
Personalized medicine is driving the need for isolation of rarer target cell populations, including for the enrichment of…
Publicly-Traded Esoteric Labs Are Off to Good Start in 2016
From - Laboratory Industry Report
As personalized medicine continues to gain traction in the United States, the publicly-traded esoteric laboratories continue to…
State Laws Highlight Need for Price Transparency
From - National Intelligence Report
Despite the fact that the majority of state legislatures have passed some laws relating to…
Compliance Certification Keeps Staff Up-to-Date, Increases Compensation
From - G2 Compliance Advisor
Laboratories should encourage or even require their compliance professionals to obtain…